Quantitative systems pharmacology-based exploration of relevant anti-amyloid therapy challenges in clinical practice Press Coverage Quantitative systems pharmacology-based exploration of relevant anti-amyloid therapy challenges in clinical practice Addressing practical challenges in clinical practice after the recent approvals of amyloid antibodies in Alzheimer's…CertaraMay 22, 2024
CERTAINTY Europe Conference CERTAINTY Europe GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to Certara experts, industry leaders, and…CertaraMay 22, 2024
Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies On-Demand Webinar Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies Targeted radiation therapies (TRT) deliver cytotoxic radiation selectively to tumors. In recent years, oncology drug…CertaraMay 22, 2024
Certara Appoints New Chief Human Resources Officer & General Counsel Press Release Certara Appoints New Chief Human Resources Officer & General Counsel RADNOR, PA – May 21, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraMay 21, 2024
Accelerating the Progress of Kinase Inhibitors in Oncology Press Coverage Accelerating the Progress of Kinase Inhibitors in Oncology The potential of PBPK modeling in answering key questions around these drugs. Hannah Jones, PhDMasoud…CertaraMay 20, 2024
Unlocking Efficiency in Formulation Development and Approvals with MIFD & Simcyp Biopharmaceutics [APAC Webinar] On-Demand Webinar Unlocking Efficiency in Formulation Development and Approvals with MIFD & Simcyp Biopharmaceutics [APAC Webinar] Biopharmaceutical professionals can gain a significant edge in formulation development by attending this free webinar…CertaraMay 16, 2024
Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates Blog Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…CertaraMay 10, 2024
CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA Announcement CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA Partnership will provide biopharmaceutical companies with advanced tools and solutions needed to expedite research …CertaraMay 10, 2024
Accelerate your drug discovery research with D360 and Design Hub Fact Sheet Accelerate your drug discovery research with D360 and Design Hub CertaraMay 10, 2024
CERTAINTY – Japan Live Events CERTAINTY – Japan GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…CertaraMay 7, 2024